Platform
Features
Pricing
0 followers
reMYND drives the development of disease-modifying treatments against protein misfolding disorders.
Industries
Headquarters
Employees
Links
Gerard Griffioen
3 members
1 members
Vertex Pharmaceuticals
55 followers
Adverum Biotech
8 followers
AbbVie
166 followers
Loam Bio
3 followers
Dragonfly Therapeutics
1 follower
Entos
Invivyd
Zepto
52 followers
Aspire
12 followers
AG1
Syensqo
7 followers
Explore companies